Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreGet the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers
Learn MoreImproving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search JobsOctober 28, 2021
Calendar11:00am - 12:30pm
(GMT+09:00)
In recent years, Cell and Gene Therapies (CAGT) has seen tremendous growth in the Japan and Asia Pacific (JAPAC) region with a continually increasing number of biopharmaceutical companies initiating clinical trials with their innovative therapies.
As these Asia Pacific-originated programs progress, to maximize their return on investment, companies are beginning to look for ways to expand development and registration of their assets to the United States, the world's largest healthcare market.
Watch our on-demand webinar to discover how IQVIA can help you navigate the US FDA regulations of regenerative medicine therapies, take advantage of expedited programs and proactively address Chemistry, Manufacturing and Controls (CMC) considerations and ultimately increase the probability of your success.
Monica R. Shah, MD, FACC
Vice President and Head, Cell and Gene Therapy Center of Excellence
IQVIA
Hardeep Samra
Sr. Director, Head of Regulatory Strategy, Strategic Drug Development
IQVIA
Eugene Brandon
Sr. Director and Head of Translation, Cell and Gene Therapy
IQVIA
Susan McClatchey
Sr. Director Product Development, Cell and Gene Therapy
IQVIA
Kristin Baird, MD
Medical Strategy Lead, Cell and Gene Therapy
IQVIA